Literature DB >> 19805914

Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.

Sung Ok Park1, Mamta Wankhede, Young Jae Lee, Eun-Jung Choi, Naime Fliess, Se-Woon Choe, Seh-Hoon Oh, Glenn Walter, Mohan K Raizada, Brian S Sorg, S Paul Oh.   

Abstract

Arteriovenous malformations (AVMs) are vascular anomalies where arteries and veins are directly connected through a complex, tangled web of abnormal arteries and veins instead of a normal capillary network. AVMs in the brain, lung, and visceral organs, including the liver and gastrointestinal tract, result in considerable morbidity and mortality. AVMs are the underlying cause of three major clinical symptoms of a genetic vascular dysplasia termed hereditary hemorrhagic telangiectasia (HHT), which is characterized by recurrent nosebleeds, mucocutaneous telangiectases, and visceral AVMs and caused by mutations in one of several genes, including activin receptor-like kinase 1 (ALK1). It remains unknown why and how selective blood vessels form AVMs, and there have been technical limitations to observing the initial stages of AVM formation. Here we present in vivo evidence that physiological or environmental factors such as wounds in addition to the genetic ablation are required for Alk1-deficient vessels to develop to AVMs in adult mice. Using the dorsal skinfold window chamber system, we have demonstrated for what we believe to be the first time the entire course of AVM formation in subdermal blood vessels by using intravital bright-field images, hyperspectral imaging, fluorescence recordings of direct arterial flow through the AV shunts, and vascular casting techniques. We believe our data provide novel insights into the pathogenetic mechanisms of HHT and potential therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805914      PMCID: PMC2769195          DOI: 10.1172/JCI39482

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease.

Authors:  Ronald Kurstin
Journal:  Oncology (Williston Park)       Date:  2002-01       Impact factor: 2.990

Review 2.  Novel insights into wound healing sequence of events.

Authors:  Liora Braiman-Wiksman; Inessa Solomonik; Ram Spira; Tamar Tennenbaum
Journal:  Toxicol Pathol       Date:  2007-10       Impact factor: 1.902

Review 3.  Potential solutions for confocal imaging of living animals.

Authors:  Claudette St Croix; Warren R Zipfel; Simon C Watkins
Journal:  Biotechniques       Date:  2007-07       Impact factor: 1.993

Review 4.  Notch signaling in vascular development and physiology.

Authors:  Thomas Gridley
Journal:  Development       Date:  2007-07-04       Impact factor: 6.868

Review 5.  Multiphoton microscopy for blood vessel imaging: new non-invasive tools (Spectral, SHG, FLIM).

Authors:  E Werkmeister; H Kerdjoudj; L Marchal; J F Stoltz; D Dumas
Journal:  Clin Hemorheol Microcirc       Date:  2007       Impact factor: 2.375

6.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

7.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.

Authors:  Marion Scharpfenecker; Maarten van Dinther; Zhen Liu; Rutger L van Bezooijen; Qinghai Zhao; Laurie Pukac; Clemens W G M Löwik; P ten Dijke
Journal:  J Cell Sci       Date:  2007-02-20       Impact factor: 5.285

8.  Health-related quality of life in hereditary hemorrhagic telangiectasia.

Authors:  Urban W Geisthoff; Katinka Heckmann; Roberto D'Amelio; Stefan Grünewald; Dirk Knöbber; Peter Falkai; Jochem König
Journal:  Otolaryngol Head Neck Surg       Date:  2007-05       Impact factor: 3.497

9.  Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation.

Authors:  Gregory T Lesnik; Douglas A Ross; Katharine J Henderson; John K Joe; Steven B Leder; Robert I White
Journal:  Am J Rhinol       Date:  2007 May-Jun

Review 10.  Regulation of vascular morphogenesis by Notch signaling.

Authors:  Cristina Roca; Ralf H Adams
Journal:  Genes Dev       Date:  2007-10-15       Impact factor: 11.361

View more
  121 in total

1.  Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia 1.

Authors:  Anthony Cannavicci; Qiuwang Zhang; Si-Cheng Dai; Marie E Faughnan; Michael J B Kutryk
Journal:  Can J Physiol Pharmacol       Date:  2018-12-04       Impact factor: 2.273

2.  Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.

Authors:  Wan Zhu; Daniel Saw; Miriam Weiss; Zhengda Sun; Meng Wei; Sonali Shaligram; Sen Wang; Hua Su
Journal:  Transl Stroke Res       Date:  2018-12-03       Impact factor: 6.829

3.  Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Authors:  Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

4.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

5.  VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.

Authors:  Chul Han; Se-Woon Choe; Yong Hwan Kim; Abhinav P Acharya; Benjamin G Keselowsky; Brian S Sorg; Young-Jae Lee; S Paul Oh
Journal:  Angiogenesis       Date:  2014-06-24       Impact factor: 9.596

6.  De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.

Authors:  Wanqiu Chen; Zhengda Sun; Zhenying Han; Kristine Jun; Marine Camus; Mamta Wankhede; Lei Mao; Tom Arnold; William L Young; Hua Su
Journal:  Stroke       Date:  2014-01-23       Impact factor: 7.914

7.  Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.

Authors:  Mamta Wankhede; Nikita Agarwal; Rodrigo A Fraga-Silva; Casey deDeugd; Mohan K Raizada; S Paul Oh; Brian S Sorg
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

8.  Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Authors:  Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

Review 9.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice.

Authors:  Qi Hao; Yiqian Zhu; Hua Su; Fanxia Shen; Guo-Yuan Yang; Helen Kim; William L Young
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.